Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Ulcerative Colitis With Novel Therapeutics
NCT06420375Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- May 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of BRS201 in ulcerative colitis (UC), sponsored by Brigham and Women's Hospital. Started May 2025; status: recruiting.
02
Drugs
BRS201
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT06420375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06420375.